<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34085109</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Acetylcholinesterase inhibitor responsive myasthenia in a Filipino male with X-linked recessive spinal and bulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>4317</StartPage><EndPage>4320</EndPage><MedlinePgn>4317-4320</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-021-05358-0</ELocationID><Abstract><AbstractText>We report a 51-year-old male diagnosed with X-linked recessive spinal and bulbar muscular atrophy (SBMA) by genetic testing who presented with 30&#xa0;years history of progressive proximal and bulbar weakness responsive to cholinesterase inhibitor. Although the anti-acetylcholine receptor antibody (anti-AChR Ab) was negative, the myasthenic state was confirmed by decremental response in repetitive nerve stimulation and increased jitter frequency and blocking in single fiber-electromyography. While myasthenia gravis and SBMA may co-exist independently in an individual having the signs and symptoms of both conditions, the absence of anti-AChR Ab may imply that myasthenia can be an exaggerated activity-induced fatigue or weakness from the latter.</AbstractText><CopyrightInformation>&#xa9; 2021. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jamora</LastName><ForeName>Roland Dominic G</ForeName><Initials>RDG</Initials><Identifier Source="ORCID">0000-0001-5317-7369</Identifier><AffiliationInfo><Affiliation>Division of Neurology, Department of Neurosciences, College of Medicine-Philippine General Hospital, University of the Philippines Manila, Taft Avenue, Ermita, 1000, Manila, Philippines. rgjamora@up.edu.ph.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prado</LastName><ForeName>Mario B</ForeName><Initials>MB</Initials><Suffix>Jr</Suffix><Identifier Source="ORCID">0000-0003-0465-0943</Identifier><AffiliationInfo><Affiliation>Division of Neurology, Department of Neurosciences, College of Medicine-Philippine General Hospital, University of the Philippines Manila, Taft Avenue, Ermita, 1000, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>Carlos L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Neurosciences, College of Medicine-Philippine General Hospital, University of the Philippines Manila, Taft Avenue, Ermita, 1000, Manila, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Neurology, Department of Medicine, Manila Doctors Hospital, Manila, Philippines.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002800">Cholinesterase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002800" MajorTopicYN="N">Cholinesterase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="N">Muscle Weakness</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009157" MajorTopicYN="Y">Myasthenia Gravis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Activity dependent conduction block</Keyword><Keyword MajorTopicYN="N">Activity-induced weakness</Keyword><Keyword MajorTopicYN="N">CAG repeat</Keyword><Keyword MajorTopicYN="N">Myasthenia</Keyword><Keyword MajorTopicYN="N">Spinal and bulbar muscular atrophy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>4</Day><Hour>7</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34085109</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05358-0</ArticleId><ArticleId IdType="pii">10.1007/s10072-021-05358-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Breza M, Koutsis G (2019) Kennedy&#x2019;s disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. J Neurol 266:565&#x2013;573. https://doi.org/10.1007/s00415-018-8968-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8968-7</ArticleId><ArticleId IdType="pubmed">30006721</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold FJ, Merry DE (2019) Molecular mechanisms and therapeutics for SBMA/ Kennedy&#x2019;s disease. Neurotherapeutics 16:928&#x2013;947. https://doi.org/10.1007/s13311-019-00790-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00790-9</ArticleId><ArticleId IdType="pubmed">31686397</ArticleId><ArticleId IdType="pmc">6985201</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R, Sorar&#xfa; G, Grunseich C, Fratta P, Zuccaro E, Pennuto M et al (2018) Beyond motor neurons: expanding the clinical spectrum in Kennedy&#x2019;s disease. J Neurol Neurosurg Psychiatry 89:808&#x2013;812. https://doi.org/10.1136/jnnp-2017-316961</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316961</ArticleId><ArticleId IdType="pubmed">29353237</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto Y, Misawa S, Mori M, Kawaguchi N, Kanai K, Shibuya K et al (2013) Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block. Clin Neurophysiol 124:1893&#x2013;1898. https://doi.org/10.1016/j.clinph.2012.12.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2012.12.053</ArticleId><ArticleId IdType="pubmed">23643309</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS et al (2000) Myasthenia gravis: recommendations for clinical research standards: task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology 55:16&#x2013;23. https://doi.org/10.1212/wnl.55.1.16</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.55.1.16</ArticleId><ArticleId IdType="pubmed">10891897</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevic Z, Peric S, Pavlovic S, Basta I, Lavrnic D (2014) Myasthenic symptoms in a patient with Kennedy&#x2019;s disease. Acta Neurol Belg 114:71&#x2013;73. https://doi.org/10.1007/s13760-013-0189-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-013-0189-3</ArticleId><ArticleId IdType="pubmed">23444172</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada M, Inaba A, Shiojiri T (1997) X-linked spinal and bulbar muscular atrophy with myasthenic symptoms. J Neurol Sci 146:183&#x2013;185. https://doi.org/10.1016/s0022-510x(96)00303-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(96)00303-6</ArticleId><ArticleId IdType="pubmed">9077516</ArticleId></ArticleIdList></Reference><Reference><Citation>Boz C, Kalay E, Sahin N, Velioglu S, Ozmenoglu M, Karag&#xfc;zel A (2004) Ocular myasthenia gravis associated with X-linked recessive spinal and bulbar muscular atrophy. J Clin Neuromuscul Dis 5:115&#x2013;118. https://doi.org/10.1097/00131402-200403000-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00131402-200403000-00001</ArticleId><ArticleId IdType="pubmed">19078730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaji R, Bostock H, Kohara N, Murase N, Kimura J, Shibasaki H (2000) Activity-dependent conduction block in multifocal motor neuropathy. Brain 123:1602&#x2013;1611. https://doi.org/10.1093/brain/123.8.1602</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.8.1602</ArticleId><ArticleId IdType="pubmed">10908190</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland KJ, Beilin J, Castro J, Varghese PN, Zajac JD (2004) Polymorphic CAG repeat length in the androgen receptor gene and association with neurodegeneration in a heterozygous female carrier of Kennedy&#x2019;s disease. J Neurol 251:35&#x2013;41. https://doi.org/10.1007/s00415-004-0266-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-004-0266-x</ArticleId><ArticleId IdType="pubmed">14999487</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>